FDA Clears First Neurostimulation Device for PTSD

Neurovalens' Modius Spero has received FDA approval as the first neuromodulation device for treating PTSD symptoms, with veterans set to gain access through the VA this summer. This represents a milestone in psychiatric device innovation and healthcare technology.